Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Randomized Placebo-Controlled Study of ISA247 in Plaque Psoriasis (SPIRIT)

This study has been completed.
Sponsor:
Information provided by:
Aurinia Pharmaceuticals Inc.
ClinicalTrials.gov Identifier:
NCT00244842
First received: October 25, 2005
Last updated: September 24, 2008
Last verified: September 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2005
  Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)
No publications provided by Aurinia Pharmaceuticals Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):